UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054433 |
|---|---|
| Receipt number | R000062172 |
| Scientific Title | A Comparison of Suture Materials for the Incidence of Surgical Site Infection after Oral Oncologic Surgery with Free-flap Reconstruction: Inverse Probability of Treatment Weighting Analysis Using Propensity Scores |
| Date of disclosure of the study information | 2024/05/18 |
| Last modified on | 2024/05/18 19:43:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Comparison of Suture Materials for the Incidence of Surgical Site Infection after Oral Oncologic Surgery with Free-flap Reconstruction: Inverse Probability of Treatment Weighting Analysis Using Propensity Scores
Acronym
A Comparison of Suture Materials for the Incidence of Surgical Site Infection after Oral Oncologic Surgery with Free-flap Reconstruction: Inverse Probability of Treatment Weighting Analysis Using Propensity Scores
Scientific Title
A Comparison of Suture Materials for the Incidence of Surgical Site Infection after Oral Oncologic Surgery with Free-flap Reconstruction: Inverse Probability of Treatment Weighting Analysis Using Propensity Scores
Scientific Title:Acronym
A Comparison of Suture Materials for the Incidence of Surgical Site Infection after Oral Oncologic Surgery with Free-flap Reconstruction: Inverse Probability of Treatment Weighting Analysis Using Propensity Scores
Region
| Japan |
Condition
Condition
Oral malignancy
Classification by specialty
| Plastic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Surgical site infection (SSI) is a crucial complication in oral oncologic surgery with free-flap reconstruction. This study aimed to compare the incidence of oral SSIs associated with the use of monofilament versus braided sutures for flap fixation.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the incidence of oral SSIs
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 200 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
This retrospective observational study included patients who underwent oral oncologic surgery with simultaneous free-flap reconstruction at the National Cancer Center Hospital East, Kashiwa, Japan, from May 2020 to April 2024. All patients involving reconstruction of any part of the oral cavity with free-flaps were included.
Key exclusion criteria
Patients without a flap inserted into the oral cavity were excluded.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Takeaki |
| Middle name | |
| Last name | Hidaka |
Organization
National Cancer Center Hospital East
Division name
Department of Plastic and Reconstructive Surgery
Zip code
277-8577
Address
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
TEL
+81-4-7133-1111
tahidaka1986@gmail.com
Public contact
Name of contact person
| 1st name | Takeaki |
| Middle name | |
| Last name | Hidaka |
Organization
National Cancer Center Hospital East, Kashiwa, Japan
Division name
Department of Plastic and Reconstructive Surgery
Zip code
277-8577
Address
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
TEL
+81-4-7133-1111
Homepage URL
thidaka@east.ncc.go.jp
Sponsor or person
Institute
National Cancer Center Hospital East, Kashiwa, Japan
Institute
Department
Personal name
Funding Source
Organization
None.
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Cancer Center Hospital East
Address
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Tel
+81-4-7133-1111
thidaka@east.ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 05 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
209
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 04 | Month | 01 | Day |
Date of IRB
| 2018 | Year | 04 | Month | 13 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 05 | Month | 18 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None.
Management information
Registered date
| 2024 | Year | 05 | Month | 18 | Day |
Last modified on
| 2024 | Year | 05 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062172
